10x Genomics (TXG) Insider Trading & Ownership $14.31 +1.02 (+7.67%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends 10x Genomics (NASDAQ:TXG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.03%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$2.04 M Get TXG Insider Trade Alerts Want to know when executives and insiders are buying or selling 10x Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TXG Insider Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! 10x Genomics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/2024Benjamin J HindsonInsiderSell4,351$22.53$98,028.03 8/22/2024Justin J McanearCFOSell2,961$22.53$66,711.33 8/22/2024Serge SaxonovCEOSell6,749$22.53$152,054.97 5/22/2024Benjamin J HindsonInsiderSell4,087$24.30$99,314.10 5/22/2024Justin J McanearCFOSell2,936$24.30$71,344.80 5/22/2024Serge SaxonovCEOSell4,877$24.30$118,511.10 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today!3/4/2024Serge SaxonovCEOSell4,660$44.00$205,040.00 2/22/2024Benjamin J HindsonInsiderSell2,613$46.34$121,086.42 2/22/2024Justin J McanearCFOSell1,865$46.34$86,424.10 2/22/2024Serge SaxonovCEOSell2,821$46.34$130,725.14 2/9/2024Serge SaxonovCEOSell1,000$49.53$49,530.00 1/16/2024Serge SaxonovCEOSell4,000$45.24$180,960.00 12/14/2023Serge SaxonovCEOSell2,000$55.03$110,060.00 11/24/2023Serge SaxonovCEOSell3,723$43.72$162,769.56 11/22/2023James WilburInsiderSell3,464$43.34$150,129.76 11/22/2023Justin J McanearCFOSell1,679$43.34$72,767.86 11/22/2023Serge SaxonovCEOSell3,757$43.34$162,828.38 (Data available from 1/1/2013 forward) TXG Insider Trading Activity - Frequently Asked Questions Who is on 10x Genomics's Insider Roster? The list of insiders at 10x Genomics includes Benjamin J Hindson, Bradford Crutchfield, James Wilbur, John R Stuelpnagel, Justin J Mcanear, Mathai Mammen, Serge Saxonov, and Sridhar Kosaraju. Learn more on insiders at TXG. What percentage of 10x Genomics stock is owned by insiders? 10.03% of 10x Genomics stock is owned by insiders. Learn more on TXG's insider holdings. Which 10x Genomics insiders have been selling company stock? The following insiders have sold TXG shares in the last 24 months: Benjamin J Hindson ($1,883,953.50), James Wilbur ($1,213,630.60), John R Stuelpnagel ($548,900.00), Justin J Mcanear ($580,588.40), Mathai Mammen ($1,743,060.00), and Serge Saxonov ($4,819,344.30). How much insider selling is happening at 10x Genomics? Insiders have sold a total of 221,572 10x Genomics shares in the last 24 months for a total of $10,789,476.80 sold. 10x Genomics Key ExecutivesDr. Serge Saxonov Ph.D. (Age 47)Co-Founder, CEO & Director Compensation: $925.05kDr. Benjamin J. Hindson Ph.D. (Age 49)Co-Founder, President, Chief Scientific Officer & Director Compensation: $618.32kMr. Eric S. Whitaker Esq. (Age 57)Chief Legal Officer Compensation: $615.38kMr. Michael Schnall-LevinFounding Scientist & CTOMs. Cassie CorneauManager of Investor Relations and Strategic FinanceMs. Rebecca PortChief People OfficerMr. Jens DurruthyAssociate Director of Product Management More Insider Trading Tools from MarketBeat Related Companies Cytek Biosciences Insider Selling Standard BioTools Insider Selling EyePoint Pharmaceuticals Insider Selling Pacific Biosciences of California Insider Selling Quanterix Insider Selling Nautilus Biotechnology Insider Selling Seer Insider Selling Akoya Biosciences Insider Selling Harvard Bioscience Insider Selling Singular Genomics Systems Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:TXG) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored25X predicted for “Amazon Coin” – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
